|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/164 | |
| A61K 31/56 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2493466 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10782039.1 |
| Europos patento paraiškos padavimo data | 2010-10-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-09-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2010/054866 |
| Data | 2010-10-27 |
| (87) | Numeris | WO 2011/051894 |
| Data | 2011-05-05 |
| (30) | Numeris | Data | Šalis |
| 256160 P | 2009-10-29 | US | |
| 293903 P | 2010-01-11 | US | |
| 355834 P | 2010-06-17 | US | |
| 355888 P | 2010-06-17 | US | |
| 369929 P | 2010-08-02 | US | |
| 383933 P | 2010-09-17 | US | |
| 389969 P | 2010-10-05 | US |
| (72) |
GUPTA, Sunil, US
|
| (73) |
Sanofi Mature IP,
54 rue la Boétie, 75008 Paris,
FR
|
| (54) | NOVEL ANTITUMORAL USE OF CABAZITAXEL |
| NOVEL ANTITUMORAL USE OF CABAZITAXEL |